tlooto

The JAK/STAT signaling pathway: from bench to clinic

Xiaoying Hu, Jing Li, Maorong Fu, Xia Zhao, Wei Wang

2021.11.26Signal Transduction and Targeted Therapy

Paper details

Journal
Signal Transduction and Targeted Therapy
Published
2021.11.26
Citations
2,152
References
568
Access
Open Access
Fields
Medicine

tlooto Summary

In this review, the current knowledge about the composition, activation, and regulation of the JAK/STAT pathway is discussed and the role of this signaling pathway and its inhibitors in various diseases is highlighted.

Abstract

The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway was discovered more than a quarter-century ago. As a fulcrum of many vital cellular processes, the JAK/STAT pathway constitutes a rapid membrane-to-nucleus signaling module and induces the expression of various critical mediators of cancer and inflammation. Growing evidence suggests that dysregulation of the JAK/STAT pathway is associated with various cancers and autoimmune diseases. In this review, we discuss the current knowledge about the composition, activation, and regulation of the JAK/STAT pathway. Moreover, we highlight the role of the JAK/STAT pathway and its inhibitors in various diseases.

Citation format

HU, Xiaoying, et al. The JAK/STAT signaling pathway: From bench to clinic. Signal Transduction and Targeted Therapy, 2021, 6(1): 402.